Literature DB >> 23552627

Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.

Joerg Latus1, Renate Lehmann, Meike Roesel, Peter Fritz, Niko Braun, Christoph Ulmer, Wolfgang Steurer, Dagmar Biegger, German Ott, Juergen Dippon, M Dominik Alscher, Martin Kimmel.   

Abstract

BACKGROUND/AIMS: Secondary hyperparathyroidism (sHPT) is known as a very common complication in patients with chronic kidney disease, and G-protein-coupled calcium-sensing receptor (CaSR), Vitamin D receptor (VDR) and Fibroblast growth factor receptor (FGFR)/Klotho complexes seem to be involved in its development.
METHODS: Hyperplastic parathyroid glands from 70 sHPT patients and normal parathyroid tissue from 7 patients were obtained during parathyroidectomy. Conventional morphological and immunohistochemical analysis of parathyroid glands was performed after dividing each slide in a 3x3 array.
RESULTS: The presence of lipocytes in the normal parathyroid gland and tissue architecture (nodal in patients with sHPT) allows for discrimination between normal parathyroid glands and parathyroid glands of patients with sHPT. Protein expression of Klotho, FGFR, CaSR and VDR was higher in the normal parathyroid glands compared to the sHPT group (p<0.001, p=0.07, p =0.01 and p=0.001). The variability of each protein expression within each tissue slide was high. Therefore correlations between the different immunohistochemical variables were analyzed for each of the nine fields and than analyzed for all patients. Using this analysis, a highly significant positive correlation could be found between the expression of FGFR and VDR (p=0.0004). Interestingly, in terms of VDR we found a shift to a more mixed nuclear/cytoplasmic staining in the HPT group compared to normal parathyroid gland cells, which showed solitary nuclear staining for VDR (p>0.05).
CONCLUSIONS: CaSR, VDR and an impaired Klotho-FGFR-axis seem to be the major players in the development of sHPT. Whether the detected correlation between FGFR and VDR and the shift to a more mixed nuclear/cytoplasmic staining of VDR will yield new insights into the pathogenesis of the disease has to be evaluated in further studies.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552627     DOI: 10.1159/000343403

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  9 in total

1.  Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform.

Authors:  Geetika Sethi; Gaurav Chopra; Ram Samudrala
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

2.  Implications of regulator of G-protein signaling 5 expression in the pathogenesis of primary and secondary hyperparathyroidism.

Authors:  Xin Li; Yao Lu; Ling Zhang; Aiping Song; Honglei Zhang; Bo Pang; Jun Liu; Xiaoliang Sun; Haoyang Ji; Linping Huang; Meng Yang
Journal:  BMC Endocr Disord       Date:  2022-06-09       Impact factor: 3.263

3.  Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.

Authors:  Yi Fan; Weiqing Liu; Ruiye Bi; Michael J Densmore; Tadatoshi Sato; Michael Mannstadt; Quan Yuan; Xuedong Zhou; Hannes Olauson; Tobias E Larsson; Hakan R Toka; Martin R Pollak; Edward M Brown; Beate Lanske
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-04       Impact factor: 11.205

4.  Calcium-sensing receptor signaling - How human disease informs biology.

Authors:  Caroline M Gorvin
Journal:  Curr Opin Endocr Metab Res       Date:  2020-07-02

5.  Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.

Authors:  Cynthia S Ritter; Sarah Zhang; James Delmez; Jane L Finch; Eduardo Slatopolsky
Journal:  Kidney Int       Date:  2015-02-18       Impact factor: 10.612

6.  Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism.

Authors:  Saime Paydas; Arbil Acikalim; Bulent Kaya; Bermal Hasbay Bicer; Mehmet Ulker; Orhan Demircan; Aysun Uguz; Mustafa Balal; Gurhan Sakman; Yasar Sertdemir; Refika Karaer; Eda Altun
Journal:  Indian J Endocrinol Metab       Date:  2014-11

7.  1,25(OH)2D3 dependent overt hyperactivity phenotype in klotho-hypomorphic mice.

Authors:  Christina B Leibrock; Jakob Voelkl; Makoto Kuro-O; Florian Lang; Undine E Lang
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

8.  Cinacalcet versus Placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis.

Authors:  Guoqi Wang; Hongyan Liu; Chengzhi Wang; Xiaojian Ji; Weijun Gu; Yiming Mu
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

9.  PTH hypersecretion triggered by a GABAB1 and Ca2+-sensing receptor heterocomplex in hyperparathyroidism.

Authors:  Wenhan Chang; Chia-Ling Tu; Frederic G Jean-Alphonse; Amanda Herberger; Zhiqiang Cheng; Jenna Hwong; Hanson Ho; Alfred Li; Dawei Wang; Hongda Liu; Alex D White; Insoo Suh; Wen Shen; Quan-Yang Duh; Elham Khanafshar; Dolores M Shoback; Kunhong Xiao; Jean-Pierre Vilardaga
Journal:  Nat Metab       Date:  2020-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.